News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Alliances
Vernalis PLC (VNLPY.PK): Update On AUY922 Development Programme 12/19/2014
Achievement Of Multiple Milestones In Evotec AG (EVTG.F)'s Drug Discovery Alliances 12/19/2014
RXi Pharmaceuticals (RXII) Expands Its Clinical Pipeline With An Exclusive Global License For A Second Phase 2 Clinical Compound 12/19/2014
PreventionGenetics LLC Teams Up With Seattle Children's Hospital PLUGS Program To Enhance Utilization Management 12/19/2014
Vernalis PLC (VNLPY.PK) Stumbles As Novartis AG (NVS) Abandons Work On AUY922 12/19/2014
Eli Lilly (LLY), Adocia Ink $570 Million Pact To Develop Fast-Acting Insulin 12/19/2014
Cytori Therapeutics, Inc. (CYTX) And Biomedical Advanced Research and Development Authority (BARDA) Amend Contract Option To Accelerate The Advancement Of A Thermal Burn Injury Countermeasure 12/19/2014
Sorrento Therapeutics, Inc. And Conkwest Announce Exclusive Global Collaboration 12/19/2014
AMMS-CanSino To Start Clinical Trial Of China Ebola Vaccine 12/19/2014
Ono Pharmaceutical Company, Ltd. And Gilead Sciences, Inc. (GILD) Announce Exclusive License Agreement To Develop BTK Inhibitor, ONO-4059, For The Treatment Of B-Cell Malignancies And Other Diseases 12/19/2014
Biothera Participates In Cancer Research UK Combinations Alliance 12/18/2014
AHF: Florida Reaches Agreement With Humana, Inc. (HUM) On HIV/AIDS Drug Pricing 12/18/2014
SoCal's Xencor Snags $175 Million+ R&D Pact With Novo Nordisk A/S (NVO) 12/18/2014
Halozyme Therapeutics, Inc. (HALO) Strikes $581 Million R&D Pact With Johnson & Johnson (JNJ) 12/18/2014
Chimerix, Inc. (CMRX) And ContraVir Pharmaceuticals Establish Strategic Collaboration For Antiviral Drug Candidate CMX157 12/18/2014
HUYA Bioscience International Establishes Alliance Wth China Wuqing Development Area 12/18/2014
The Medicines Company (MDCO) Reaches $55 Million Licensing Partnership With SciClone Pharmaceuticals, Inc. (SCLN) 12/18/2014
Enamine Ltd. Announces Extension Of Collaboration With Sanofi (SAN.PA) In Early Drug Discovery 12/18/2014
Compugen Ltd. (CGEN) Enters Immuno-Oncology Research Collaboration With Johns Hopkins University 12/18/2014
Cellectis Plant Sciences And Two Blades Foundation Announce The Execution Of A Cross-License Agreement On TAL Effector Nuclease Technologies 12/18/2014
Strategic Science & Technologies Signs Partnership Agreement With A Leading Global Pharmaceutical Company For U.S. Commercial Rights To Topical Ibuprofen 12/18/2014
Indi Molecular® And Sigma-Aldrich Corporation (SIAL) Establish Collaboration To Explore Use Of PCC Technology In Biological Tools 12/18/2014
Enumeral Biomedical (ENUM) And Merck & Co. (MRK) Form Collaboration For Predicting Clinical Drug Response With Human-Driven Immune Profiling Platform 12/18/2014
Marina Biotech, Inc. (MRNA), MiNA Therapeutics Ink $50 Million R&D Pact 12/18/2014
Axxess Pharma, Inc. Forms Partnership With Roc Nation Sports And Throne Boxing In Promotion Of Tapout Product Line 12/18/2014
WIL Research Partners With Instem For Global Harmonization Project 12/18/2014
Amunix, Inc. Announces Option Exercise By Eli Lilly (LLY) For XTEN™ Product For People With Diabetes 12/18/2014
Biotech Billionaire Bets $20 Million On Sorrento Therapeutics, Inc. 12/17/2014
Alexza Pharmaceuticals, Inc. (ALXA) Amends Autoliv Agreement For Heat Packages Used In ADASUVE 12/17/2014
X-Chem Licenses Cardiovascular Drug Discovery Program To Bayer Pharma AG 12/17/2014
Orexo AB (ORXOF) Receives Million 5£ Milestone Payment For Abstral® In Europe And Zubsolv® Continues Strong Market Share Growth In The US 12/17/2014
Curie-Cancer And GamaMabs Pharma SA Renew Their Research Partnership To Develop An Antibody For Gynecological Cancers 12/17/2014
Addex Therapeutics (ADXN.SW) Amends mGlu2PAM Collaboration Agreement And Receives USD757,000 12/17/2014
IBM Research Scientists Investigate Use Of Cognitive Computing-Based Visual Analytics For Skin Cancer Image Analysis 12/17/2014
Generex Biotechnology Corporation (GNBT) Announces Participation In MedCannAccessCannScience Partnership On Non-Smoked Forms Of Marijuana 12/17/2014
Opko Health, Inc. (OPK) Rockets After Striking Deal Worth $570 Million With Pfizer (PFE) 12/17/2014
Boston Strategics Corporation Enters Into An Innovative Risk-Sharing Agreement With MD Anderson Cancer Center To Conduct A Phase 1/2a Clinical Trial Of E6201 In Patients With Advanced Hematologic Malignancies Including Acute Myeloid Leukemia 12/17/2014
Wellcome Trust Sanger Institute Release: Making Single-Cell Biology Work 12/17/2014
Oncodesign SA Has Entered Into A Services Agreement With Eisai Inc. (ESALF.PK) To Develop A New Personalized Medicine Program In Earlier Line Metastatic Breast Cancer Treatment 12/17/2014
Bayer HealthCare (BAY) Appoints Cardinal Health, Inc. (CAH) As U.S. Based Contract Manufacturer For Xofigo (Radium Ra 223 Dichloride) Injection 12/16/2014
Johnson & Johnson (JNJ) Pulls Out Of Program To Develop Bowel Disease Drug 12/16/2014
Antibe Therapeutics Inc. Announces Appointment Of US-Based Investor Relations Consultant 12/16/2014
BioTime (BTX) Subsidiary ES Cell International Pte Ltd. And GE Healthcare Cross-License Patents In The Field Of Cell Assays For Drug Testing 12/16/2014
CRF Health Partners With Euroqol To Become A Preferred Ecoa Provider Granted Permission To Host Its Own Web Version Of The EQ-5D™ 12/16/2014
Regeneron (REGN), Sanofi (SAN.PA) Test The Public's Cholesterol IQ To Prep For Alirocumab Launch 12/16/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Earns $2.5 Million Milestone Payment From Bayer HealthCare (BAY) 12/16/2014
Galapagos NV (GLPG.BR) Regains Full Rights To GPR84 Inhibitor GLPG1205 12/16/2014
DURECT Corporation (DRRX) Enters Into License Agreement Granting Santen, Inc. The Worldwide Rights To A Sustained Release SABER Ophthalmology Product 12/16/2014
CMC Biologics And OncoSynergy Enter Into An Agreement For Accelerated Process Development And GMP Manufacture Of An Investigational Drug To Combat Ebola 12/16/2014
NeoGenomics, Inc. (NGNM.OB), The Robert H. Lurie Comprehensive Cancer Center Of Northwestern University, And The Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program 12/16/2014
Aseptix Signs Global Technology License With Ecolab Inc. (ECL) 12/16/2014
Carlina Technologies Signs A Partnership Agreement With Atlangram To Develop Controlled-Release Forms Of Antibiotics Targeting Osteoarticular Diseases 12/16/2014
PPD, Inc. (PPDI) And ERT Establish Strategic Partnership To Enhance Drug Development 12/16/2014
Ossianix Expands And Extends Its Research Collaboration With H. Lundbeck A/S (LUN.CO) On CNS Therapeutics 12/16/2014
Lightlake Therapeutics Inc. (LLTP), Adapt Pharma Forge Deal Worth $55 Million 12/16/2014
Expanding Orthopedics Inc. Closes First US Distribution Agreement For Its 3D Expandable Flxfit Cage 12/16/2014
Oncothyreon Inc. (ONTY) Strikes $300 Million Cancer Pact With Array BioPharma, Inc. (ARRY) 12/15/2014
Anthera Pharmaceuticals, Inc. (ANTH) Licenses Japan Rights For Blisibimod To Zenyaku Kogyo 12/15/2014
GE Healthcare Life Sciences Joins SBC's Neurodegenerative Disease Challenge 12/15/2014
CytoSorbents, Inc. Announces Strategic Partnership With Fresenius Medical Care 12/15/2014
Ignyta (RXDX) Announces Amendment To License Agreement With Nerviano Medical Sciences (NervianoMS) 12/15/2014
University of Melbourne Collaborates With Thomson Reuters To Advance Biomedical Research 12/12/2014
Johnson & Johnson (JNJ) Announces Collaboration Between Janssen Therapeutics And USAID To Expand Access To Anti-Multidrug-Resistant Tuberculosis (MDR-TB) Compound 12/12/2014
Novo Nordisk A/S (NVO) And Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement For Verizon Indycar Series 12/12/2014
Axxess Pharma, Inc. And TapouT Fitness Announce Exclusive Alliance To Supply Gyms With TapouT Products 12/12/2014
MACROGEN To Supply "X-Genome" Genome Analysis Service To Institute Of Psychiatry At King's College London 12/11/2014
Plexxikon Inc. And Quantumleap Healthcare Collaborative Announce Selection Of PLX3397 For I-SPY 2 TRIAL In Breast Cancer 12/11/2014
X-Chem And Alexion Pharmaceuticals Inc. (ALXN) Collaborate To Discover Novel Therapeutic Candidates To Treat Patients With Severe And Ultra-Rare Disorders 12/11/2014
Parent Project Muscular Dystrophy To Collaborate With Catabasis Pharmaceuticals, Inc. On CAT-1004 Development 12/11/2014
Voyager Therapeutics And MassBiologics Announce Strategic Collaboration For Viral Vector Manufacturing 12/11/2014
Nimbus Discovery Achieves First Milestone In Research Collaboration With Monsanto Company (MON) 12/10/2014
Ono Pharmaceutical Company, Ltd., Bristol-Myers Squibb Company (BMY), And Kyowa Hakko Kirin Announce Immuno-Oncology Clinical Collaboration Studying Opdivo (Nivolumab) And Mogamulizumab In Advanced Solid Tumors 12/10/2014
La Jolla Pharmaceutical Company (LJPC) And George Washington University Announce Exclusive Worldwide License Agreement 12/10/2014
UPM Pharmaceuticals To Manufacture BioPharmX's First Commercially Available Product 12/10/2014
Cystic Fibrosis Foundation Therapeutics, Inc. Announces $15 Million Research Collaboration With Shire For Development Of Novel CF Treatment 12/10/2014
TriLink BioTechnologies Secures Contract For The Synthesis Of Ebola Vaccine 12/10/2014
Luqa Pharmaceuticals In-licenses Novel Wound Product From Histocell 12/10/2014
PuraMed BioScience Completes Distribution Agreement With FastFunds Financial Corporation For Its Migraine Relief Product 12/9/2014
Calithera Biosciences, Inc. (CALA) Gains Exclusive, Worldwide License To Mars Symbioscience's Arginase Inhibitors 12/9/2014
ViaDerma Release: Tetrastem™ Antibiotic Continues To Demonstrate Treatment Success Leading Management To Explore Partnerships With Big Pharmaceutical Companies 12/9/2014
Vital Connect Partners With Medidata Solutions, Inc. To Enhance Clinical Trials With Continuous Vital Sign Monitoring 12/9/2014
PCORI And NIH Partner On Request For Applications To Study How To Improve Blood Pressure Control In High-Risk Individuals 12/9/2014
Symphogen A/S Licenses The Selexis SA SUREtechnology Expression Platform And Cell Line 12/9/2014
Society For Clinical Research Sites Welcomes Clinical Ink As New Global Impact Partner 12/9/2014
Zymeworks And Merck & Co. (MRK) Extend And Expand Bi-specific Antibody Therapeutics Collaboration 12/9/2014
Pfizer (PFE) Grabs Rights To Preclinical Drugs From Startup In $29 Million+ Deal 12/9/2014
Spark Therapeutics Strikes $280 Million Hemophilia B Pact With Pfizer (PFE) 12/9/2014
Agios Pharmaceuticals (AGIO) Announces Celgene (CELG) Decision To Extend Discovery Phase Of Global Strategic Collaboration To April 2016 12/8/2014
Leading Bone Repair Company BoneSupport And Regenerative Medicine Company Orthocell Announce A Heads Of Agreement 12/8/2014
ZoBio And Domainex Ltd Join Forces To Deliver Crucial Drug Target Information To Support FORMA Therapeutics, Inc.’ Drug Discovery Programs 12/8/2014
SYGNIS AG Signs Initial Non-Exclusive Distribution Agreement For Its First Proprietary Product With BioCat GmbH 12/8/2014
Eli Lilly (LLY), Anthem, Inc., And HealthCore Create Research Collaboration To Improve Health Outcomes 12/8/2014
Kapa Biosystems Expands Partnership With Roche NimbleGen, Inc To Include RNA Sample Preparation For Targeted Next-Gen Sequencing 12/8/2014
Pfizer (PFE) Expands Rare Disease Research With Establishment Of Gene Therapy Platform 12/8/2014
Dynavax Technologies Corporation (DVAX) And AstraZeneca PLC (AZN) To Advance TLR9 Agonist For Treatment Of Asthma Into Phase 2a Clinical Study 12/8/2014
In Ovations Holdings, Inc. Enters Into Sales And Marketing Agreement With Regulon, Inc. Expanding Its Cancer Detection Offerings To Include Cancer Treatment Solutions 12/8/2014
Easton Pharmaceuticals (OP: EAPH) Announces Positive Updates, Changes To Its OTC Therapeutic Products, Manufacturing And North American Distributorship 12/8/2014
Good Start Genetics, Inc. Announces Exclusive License Agreement With Johns Hopkins University For Key Assets In Preimplantion Genetic Screening 12/8/2014
NovaBay Pharmaceuticals, Inc. (NBY) Signs Distribution Agreement With The Biopharm Group 12/8/2014
Agilent Technologies Inc. (A) And Baylor College of Medicine Open Center Of Excellence In Mass Spectrometry 12/5/2014
Aldeyra Therapeutics (ALDX) Announces Collaboration With TheNational Organization for Rare Disorders To Enhance Awareness For Sjogren-Larsson Syndrome Patients 12/5/2014
Juno Therapeutics Executes License For Phase I CAR T Product Candidate Targeting CD22 For Hematological Malignancies 12/5/2014
Evotec AG (EVTG.F) Seals $310M Research Deal; Acquires Sanofi (SAN.PA)'s Toulouse Operations 12/4/2014
SAB Biotherapeutics And US Army Team Up To Treat Hantavirus 12/4/2014
CTI BioPharma Receives $15 Million Milestone Payment for TRISENOX 12/4/2014
Pluristem Therapeutics (PSTI) And Hadassah Medical Center Will Collaborate To Study Potential Of PLX-RAD Cells To Improve Bone Marrow And Umbilical Cord Blood Transplant Outcomes 12/4/2014
The ALS Association And Muscular Dystrophy Association Team Up To Advance ALS Therapy Concept 12/4/2014
Sigma-Aldrich Corporation (SIAL) Life Sciences Licenses Foundational CRISPR Patents From Broad Institute 12/4/2014
UCB, Georgia Institute of Technology Partner To Harness The Power Of Predictive Analytics In Epilepsy Care 12/4/2014
Thomson Reuters And Linguamatics Release New Solution To Advance Pharma Clinical Trial R&D 12/4/2014
GE Healthcare Life Sciences Release: Licenses CRISPR Gene Engineering Technology Patents From Broad Institute 12/4/2014
Array BioPharma, Inc. (ARRY) Regains Worldwide Rights To Cancer Drug From Novartis AG (NVS) 12/4/2014
Euclises Pharmaceuticals Announces Development Agreement With GIBH 12/3/2014
The Binding Site And eBioscience, Inc., An Affymetrix (Santa Clara, California) (AFFX) Business, Partner In Clinical Flow Cytometry Reagent Agreement 12/3/2014
PacificGMP And Ohio Clinical Trials Collaborative Launch Partnership 12/3/2014
Garmatex Technologies, Inc. Release: New Partnership Aims To Produce Innovative Healthcare Products To Prevent The Spread Of Deadly Illnesses In Hospitals 12/3/2014
RxTrials And Clinical Oncology Research Excellence (CORE) Announce A Strategic Collaboration To Launch A Cancer Specific Investigative Site Network (ISN) 12/3/2014
VTU Technology And RCT Announce Partnership 12/3/2014
Nexvet Announces Collaboration And Distribution Agreement With Virbac 12/3/2014
Astellas Pharma Inc. (ALPMY), Janssen Biotech Inc. (JNJ) To End Collaboration On RA Drug ASP015K 12/2/2014
Zosano Pharma, Inc. And Eli Lilly (LLY) Enter Into Exclusive Licensing Agreement For Zosano's ZP-PTH Product Candidate 12/2/2014
BBK Worldwide And ACRES Collaborate On Patient Role In Research 12/2/2014
GeNeuro, Servier Ink $455M MS Drug Pact 12/2/2014
Vital Therapies, Inc. (VTI) (VTL) Readies Clinical & Regulatory Operations With End-To-End Regulated Content Management Solution In The Cloud From Veeva Systems, Inc. 12/2/2014
McKesson Corporation And Celesio To Operate As An Integrated Company—Achieving Important Acquisition Milestone 12/2/2014
Onco360 Selected By Pfizer (PFE)r As Limited Distribution Pharmacy Provider; Expands Onco360’s Industry-Leading Portfolio To Nearly 40 Products 12/2/2014
BioVersys AG And Enamine Ltd. Announce Extension Of Drug Discovery Collaboration To Address Multidrug-Resistant Bacterial Infections 12/2/2014
Nurix Launches Collaboration With Mount Sinai Hospital’s Lunenfeld-Tanenbaum Research Institute To Expand Its Drug Discovery Program 12/2/2014
Edeniq And Global Bio-chem Enter Into Joint Development Agreement 12/2/2014
BioAmber Inc. Signs Exclusive Supply Agreement For Bio-Succinic Acid In Lubricants 12/2/2014
Southern Research Continues 24 Years Of HIV Work With New NIH Contract 12/2/2014
ChromaDex, Inc. Licenses Exclusive Worldwide Patent Rights From The University Of Mississippi For Microalgae Technology Targeting Immune Support 12/2/2014
Unilife Corporation (UNIS) Signs Long-Term Commercial Supply Agreement For Use Of Depot-Ject Delivery System With Approved Ocular Injection Drug 12/2/2014
Atreca, Inc., Establishes Strategic Collaboration With Johnson & Johnson Innovation (JNJ) And Janssen Biotech Inc. (JNJ) To Apply Immune Repertoire Capture™ Technology To Autoimmune Disease 12/2/2014
Nuvilex (NVLX) Obtains Exclusive Worldwide License To Develop Disease Treatments That Combine Cell-In-A-Box(R) And Cannabinoid-Based Medicine 12/2/2014
Foundation Medicine, Inc. (FMI) And Flatiron Health Collaborate To Develop First-in-Class Data Platform To Accelerate Precision Medicine For Cancer 12/2/2014
Tesaro, Inc. (TSRO) And AnaptysBio, Inc. Expand Immuno-Oncology Collaboration To Include Novel Bispecific Antibody Candidate 12/2/2014
OncoSec Medical Inc. Collaborates With PerkinElmer, Inc. (PKI) And University of California, Los Angeles (UCLA) To Evaluate Patient-Selection Biomarker In Immunotherapy 12/2/2014
Imprimis Pharmaceuticals (immy) Signs Agreement To Acquire PCAB-Accredited Pharmacy In California 12/2/2014
Vaccinex, Inc. And Janssen Enter Into A Collaboration For The Creation Of Novel Anti-Cancer Agents 12/2/2014
Mylan Inc. (MYL), Gilead Sciences, Inc. (GILD) Ink Agreement Covering Non-Exclusive TAF Rights 12/1/2014
Sanofi (SAN.PA), Pozen, Inc. (POZN) Terminate U.S. License Agreement For Gastric Ulcer Drugs 12/1/2014
Dynavax Technologies Corporation (DVAX) Regains Full Rights To Investigational TLR 7/9 Inhibitor DV1179 Following Expiration Of Collaboration With GlaxoSmithKline (GSK) 12/1/2014
AEterna Zentaris (AEZS) And Sinopharm A-Think Sign Master Collaboration Agreement For Zoptarelin Doxorubicin In China 12/1/2014
HanAll BioPharma Co., Ltd. (009420.KS) And Open Monoclonal Technology Announce Collaboration 12/1/2014
TG Therapeutics, Inc. (MHA) Announces Collaboration For A Clinical Trial Of TGR-1202 In Combination With Ibrutinib (Imbruvica) For Patients With Select B-Cell Malignancies 12/1/2014
European Patent Office Grants Broad RNAa Patent From Corey Estate Exclusively Licensed By MiNA Therapeutics 12/1/2014
Editas Medicine Licenses Genome Editing Technology From Duke University 12/1/2014
Broad Institute, Harvard University, And Massachusetts Institute of Technology (MIT) License CRISPR-Cas9 Technology To Editas Medicine For Therapeutic Applications 12/1/2014
Toshiba Corporation Selects Affymetrix (Santa Clara, California) (AFFX) Axiom Platform For Its Newly Launched Genotyping Service In Japan 12/1/2014
Editas Medicine Licenses Genome Editing Technology From Massachusetts General Hospital 12/1/2014
Pozen, Inc. (POZN) And Sanofi US (SNY) Mutually Agree To Terminate U.S. Partnership For PA8140/PA32540 12/1/2014
Nordic Nanovector And Affibody Collaborate On Advanced Radio-Immunotherapies Program For Multiple Myeloma 12/1/2014
Flamel Technologies (FLML) Sells Development And Manufacturing Facility In Pessac, France To Recipharm AB 12/1/2014
IP Group plcModern Biosciences plc Announces Collaboration Worth Up To £176m With Johnson & Johnson (JNJ) Innovation And Janssen Biotech Inc. (JNJ) 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
Editas Medicine Licenses Genome Editing Technology From Broad Institute And Harvard University 12/1/2014
nanoPET Pharma Initiates R&D Partnership With Boehringer Ingelheim Corporation 12/1/2014
IXICO Announces Enhanced Contracts With Two Pharmaceutical Company Customers In Huntington's Disease 11/26/2014
Nordic Nanovector And Affibody Collaborate On New Advanced Radio-Immunotherapies Program For Multiple Myeloma 11/26/2014
$1 Billion Oncology Alliance Between Menarini Group & Oxford BioTherapeutics Initiates First-In-Human Study Of Enhanced Antibody For Treatment Of Acute Myeloid Leukemia 11/25/2014
Breckenridge Pharmaceutical, Inc. Signs Multi-Product Generic Agreement With Pharmaceutics International, Inc. 11/25/2014
University of California, San Francisco (UCSF) And OncoSec Medical Inc. Collaborate To Evaluate Investigational Combination Of ImmunoPulse And Anti-PD-1 Treatment 11/25/2014
Parent Project Muscular Dystrophy And Santhera Pharmaceuticals AG (SANN.SW) Team Up On Benefit/Risk Study In Duchenne 11/25/2014
Paragon Bioservices Wins NIH Contract For Design & Scale-Up Manufacturing Of rhE -Selectin Protein 11/25/2014
Zymeworks Announces Research Collaboration With Dr. Dennis J. Slamon And University of California, Los Angeles (UCLA) 11/25/2014
Bristol-Myers Squibb Company (BMY) And Five Prime Therapeutics, Inc. (FPRX) Announce Exclusive Clinical Collaboration To Evaluate The Combination Of Investigational Immunotherapies Opdivo (nivolumab) And FPA008 In Six Tumor Types 11/24/2014
Drug Giant Merck & Co. (MRK) Buys Rights To NewLink Genetics Ebola Vaccine rVSV-EBOV 11/24/2014
GlaxoSmithKline (GSK) Shareholders To Vote On Novartis AG (NVS) Deal On Dec. 18 11/24/2014
Trimel Pharmaceuticals (TRL.TO), Endo International (ENDP) Ink NATESTO Deal For Up To $195M 11/24/2014
Sevion Therapeutics Announces Chimerasome Research Agreement 11/24/2014
Boston Therapeutics, Inc. and Advance Pharmaceutical Expand Agreement To Market Sugardown® In 12 Additional Countries In Asia 11/24/2014
MRC Technology And Yabao Pharmaceuticals Announce Exclusive Partnership In China To Develop Novel Therapeutics For Parkinson’s Disease 11/24/2014
Chembio Diagnostics, Inc. (CEMI.OB) Signs Agreement With CDC Contractor To Develop A Multiplex Point-Of-Care Test For Influenza Immunity 11/24/2014
Omnicare, Inc. (OCR) And McKesson Corporation Expand Distribution Agreement 11/24/2014
Camurus, Braeburn Pharmaceutical Ink Licensing Deal Worth Up To $151 Million 11/21/2014
Coquí RadioPharmaceuticals Inks Deal With INVAP 11/21/2014
Yabao Pharmaceuticals And MRC Technology Announces Exclusive China Partnership 11/21/2014
The Dow Chemical Company (DOW) And Third Point Reach Agreement 11/21/2014
LabCorp Completes Acquisition Of LipoScience, Inc. 11/21/2014
Lincoln Park Doubles Down On Oncology With $55M Galena Biopharma  (GALE) Bet 11/21/2014
Ironwood Pharmaceuticals (IRWD) Earns $15 Million Milestone From Astellas Pharma Inc. (ALPMY) 11/20/2014
OncoSec Medical Inc. And University of Washington Enter Sponsored Research Agreement 11/20/2014
Sunshine Biopharma, Inc. Signs Agreement With Lonza Biologics Inc. (LONN.VX) To Manufacture Its Lead Anti-Cancer Compound, Adva-27a 11/20/2014
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine 11/20/2014
California Institute of Technology, City of Hope Collaborate To Advance Scientific Breakthroughs, Medical Research 11/20/2014
Anthera, Inc. And Patheon Inc. (PTI.TO) Sign Manufacturing Agreement For Liprotamase Phase 3 Registration Trial 11/20/2014
PharmAthene, Inc. (PIP) Fulfills Valortim IDIQ Contract 11/20/2014
STALLERGENES And ActoGeniX To Develop An Innovative New Class Of Oral Allergy Treatments 11/20/2014
Ipsen (IPN.PA) And CNRS Create The "Archi-Pex" Joint Research And Innovation Lab, In Collaboration With The University Of Rennes 1 And CEA 11/20/2014
Aspira Scientific To Distribute Nagase's Unnatural Amino Acids For Next-Generation Drug Candidate Development 11/19/2014
Royalty Pharma Buys Royalties On Vertex Pharmaceuticals Incorporated (VRTX) Drugs For $3.3 Billion 11/19/2014
Transgenomic, Inc. (TBIO) Collaborates With Researchers To Advance Understanding Of Genetic Disease Tuberous Sclerosis 11/19/2014
Oncore Announces Exclusive HBV Research Collaboration With The Baruch S. Blumberg Institute 11/19/2014
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine 11/19/2014
Regenicin, Inc. Enters Into Asset Purchase Agreement With Amarantus Bioscience Holdings, Inc. 11/19/2014
U.S. Agency for International Development, Broad Institute, And Illumina, Inc. (ILMN) Form A Public-Private Partnership Combating The Ebola Epidemic In West Africa 11/19/2014
NYU Langone Medical Center And Lutheran Medical Center To Affiliate 11/19/2014
Ikaria Inc. And Lee's Pharmaceutical Announce Strategic Partnership For The Registration And Commercialization Of Ikaria's INOMAX Total Care Package In The People's Republic Of China, Hong Kong, Macau And Taiwan 11/19/2014
BioMed Realty Trust And Broad Institute Form Strategic Partnership To Promote Innovation And Collaboration Within The Life Science Industry 11/19/2014



//-->